# Sentinel Lymph Node Detection in Patients With Stage Ib-III Melanoma Using MSOT and ICG

> **NCT05467137** · PHASE4 · UNKNOWN · sponsor: **University Medical Center Groningen** · enrollment: 10 (estimated)

## Conditions studied

- Melanoma, Stage I
- Melanoma, Stage II
- Melanoma Stage III

## Interventions

- **DEVICE:** MSOT

## Key facts

- **NCT ID:** NCT05467137
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09
- **Primary completion:** 2022-11
- **Final completion:** 2023-03
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2022-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05467137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05467137, "Sentinel Lymph Node Detection in Patients With Stage Ib-III Melanoma Using MSOT and ICG". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT05467137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*